vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Equinix (EQIX). Click either name above to swap in a different company.
Equinix is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× BioNTech SE). Equinix runs the higher net margin — 11.0% vs -1.9%, a 12.8% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Equinix Inc. is an American multinational company headquartered in Redwood City, California. It specialized in internet connectivity and data center colocation centers, commonly known as carrier hotels until the company converted to a real estate investment trust (REIT) in January 2015.
BNTX vs EQIX — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.5B | $2.4B |
| Net Profit | $-28.7M | $265.0M |
| Gross Margin | — | 50.5% |
| Operating Margin | -3.1% | 17.4% |
| Net Margin | -1.9% | 11.0% |
| Revenue YoY | — | 8.8% |
| Net Profit YoY | — | -22.7% |
| EPS (diluted) | — | $2.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.4B | ||
| Q4 25 | — | $2.4B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $260.8M | $2.3B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | — | $2.2B |
| Q1 26 | — | $265.0M | ||
| Q4 25 | — | $265.0M | ||
| Q3 25 | $-28.7M | $374.0M | ||
| Q2 25 | $-386.6M | $368.0M | ||
| Q1 25 | — | $343.0M | ||
| Q4 24 | — | $-14.0M | ||
| Q3 24 | $198.1M | $297.0M | ||
| Q2 24 | — | $301.0M |
| Q1 26 | — | 50.5% | ||
| Q4 25 | — | 50.5% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 52.0% | ||
| Q1 25 | — | 51.3% | ||
| Q4 24 | — | 47.1% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 49.9% |
| Q1 26 | — | 17.4% | ||
| Q4 25 | — | 17.4% | ||
| Q3 25 | -3.1% | 20.5% | ||
| Q2 25 | -192.1% | 21.9% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | 0.8% | 19.3% | ||
| Q2 24 | — | 20.2% |
| Q1 26 | — | 11.0% | ||
| Q4 25 | — | 11.0% | ||
| Q3 25 | -1.9% | 16.1% | ||
| Q2 25 | -148.2% | 16.3% | ||
| Q1 25 | — | 15.4% | ||
| Q4 24 | — | -0.6% | ||
| Q3 24 | 15.9% | 13.5% | ||
| Q2 24 | — | 13.9% |
| Q1 26 | — | $2.70 | ||
| Q4 25 | — | $2.70 | ||
| Q3 25 | — | $3.81 | ||
| Q2 25 | — | $3.75 | ||
| Q1 25 | — | $3.50 | ||
| Q4 24 | — | $-0.19 | ||
| Q3 24 | — | $3.10 | ||
| Q2 24 | — | $3.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $3.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $14.2B |
| Total Assets | — | $40.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $3.7B | ||
| Q4 24 | — | $3.6B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $17.3B | ||
| Q2 25 | — | $18.1B | ||
| Q1 25 | — | $15.9B | ||
| Q4 24 | — | $15.3B | ||
| Q3 24 | — | $15.4B | ||
| Q2 24 | — | $14.5B |
| Q1 26 | — | $14.2B | ||
| Q4 25 | — | $14.2B | ||
| Q3 25 | — | $14.2B | ||
| Q2 25 | — | $14.1B | ||
| Q1 25 | — | $13.9B | ||
| Q4 24 | — | $13.5B | ||
| Q3 24 | — | $13.6B | ||
| Q2 24 | — | $12.3B |
| Q1 26 | — | $40.1B | ||
| Q4 25 | — | $40.1B | ||
| Q3 25 | — | $38.1B | ||
| Q2 25 | — | $38.8B | ||
| Q1 25 | — | $36.1B | ||
| Q4 24 | — | $35.1B | ||
| Q3 24 | — | $35.4B | ||
| Q2 24 | — | $32.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.22× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.14× | ||
| Q4 24 | — | 1.13× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 1.18× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.